The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Minimal Change Disease
Open accessAbstract
Minimal change disease (MCD) is a major cause of idiopathic nephrotic syndrome (NS), characterized by intense proteinuria leading to edema and intravascular volume depletion. In adults, it accounts for approximately 15% of patients with idiopathic NS, reaching a much higher percentage at younger ages, up to 70%–90% in children >1 year of age. In the pediatric setting, a renal biopsy is usually not performed if presentation is typical and the patient responds to therapy with oral prednisone at conventional doses. Therefore, in this setting steroid-sensitive NS can be considered synonymous with MCD. The pathologic hallmark of disease is absence of visible alterations by light microscopy and effacement of foot processes by electron microscopy. Although the cause is unknown and it is likely that different subgroups of disease recognize a different pathogenesis, immunologic dysregulation and modifications of the podocyte are thought to synergize in altering the integrity of the glomerular basement membrane and therefore determining proteinuria. The mainstay of therapy is prednisone, but steroid-sensitive forms frequently relapse and this leads to a percentage of patients requiring second-line steroid-sparing immunosuppression. The outcome is variable, but forms of MCD that respond to steroids usually do not lead to chronic renal damage, whereas forms that are unresponsive to steroids may subsequently reveal themselves as FSGS. However, in a substantial number of patients the disease is recurrent and requires long-term immunosuppression, with significant morbidity because of side effects. Recent therapeutic advances, such as the use of anti-CD20 antibodies, have provided long-term remission off-therapy and suggest new hypotheses for disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTION
Shalhoub, R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91880-7 · Cited by 1,192
Faul, C., Donnelly, M., Merscher-Gomez, S., Chang, Y. H., Franz, S., Delfgaauw, J., Chang, J.-M., Choi, H. Y., Campbell, K. N., Kim, K., et al. (2008) · Nature Medicine · doi:10.1038/nm.1857 · Cited by 991
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
Nephrotic syndrome in childhood
Eddy, A. A., & Symons, J. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14184-0 · Cited by 954
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Focal Segmental Glomerulosclerosis
D'Agati, V. D., Kaskel, F. J., & Falk, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106556 · Cited by 825
A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome
Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050489 · Cited by 651
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes
Waldman, M., Crew, R. J., Valeri, A., Busch, J., Stokes, B., Markowitz, G., D'Agati, V., & Appel, G. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03531006 · Cited by 420
Epidemiology and Pathophysiology of Nephrotic Syndrome–Associated Thromboembolic Disease
Kerlin, B. A., Ayoob, R., & Smoyer, W. E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10131011 · Cited by 379
Ruggenenti, P., Debiec, H., Ruggiero, B., Chianca, A., Pellé, T., Gaspari, F., Suardi, F., Gagliardini, E., Orisio, S., Benigni, A., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070640 · Cited by 376
Self-citationClement, L. C., Avila-Casado, C., Macé, C., Soria, E., Bakker, W. W., Kersten, S., & Chugh, S. S. (2011) · Nature Medicine · doi:10.1038/nm.2261 · Cited by 331
Timonen, S., Nieminen, U., & Kauraniemi, T. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93163-8 · Cited by 326
Floege, J., & Amann, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00272-5 · Cited by 306
Farquhar, M. G., Vernier, R. L., & Good, R. A. (1957) · The Journal of Experimental Medicine · doi:10.1084/jem.106.5.649 · Cited by 294
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
Ponticelli, C., Rizzoni, G., Edefonti, A., Altieri, P., Rivolta, E., Rinaldi, S., Ghio, L., Lusvarghi, E., Gusmano, R., Locatelli, F., et al. (1993) · Kidney International · doi:10.1038/ki.1993.194 · Cited by 288
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO
Lombel, R. M., Gipson, D. S., & Hodson, E. M. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2310-x · Cited by 277
Fogo, A., Hawkins, E. P., Berry, P. L., Glick, A. D., Chiang, M. L., MacDonell, R. C., & Ichikawa, I. (1990) · Kidney International · doi:10.1038/ki.1990.175 · Cited by 273
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
Ruggenenti, P., Ruggiero, B., Cravedi, P., Vivarelli, M., Massella, L., Marasà, M., Chianca, A., Rubis, N., Ene-Iordache, B., Rudnicki, M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013030251 · Cited by 267
Self-citationOverexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in Rats
Lai, K. W., Wei, C., Tan, L.-K., Tan, P., Chiang, G. S. C., Lee, C. G. L., Jordan, S. C., & Yap, H. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070710 · Cited by 255
Corticosteroid therapy for nephrotic syndrome in children
Hahn, D., Hodson, E. M., Willis, N. S., & Craig, J. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001533.pub5 · Cited by 248
Mycophenolate mofetil treatment for primary glomerular diseases
Choi, M. J., Eustace, J. A., Gimenez, L. F., Atta, M. G., Scheel, P. J., Sothinathan, R., & Briggs, W. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00214.x · Cited by 231
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome
Colucci, M., Carsetti, R., Cascioli, S., Casiraghi, F., Perna, A., Ravà, L., Ruggiero, B., Emma, F., & Vivarelli, M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050523 · Cited by 227
Self-citationSteroid-sensitive nephrotic syndrome: From childhood to adulthood
Fakhouri, F., Bocquet, N., Taupin, P., Presne, C., Gagnadoux, M.-F., Landais, P., Lesavre, P., Chauveau, D., Knebelmann, B., Broyer, M., et al. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50116 · Cited by 188
Fleming, A., & Walters, W. (1947) · PubMed · Cited by 188
Choudhry, S., Bagga, A., Hari, P., Sharma, S., Kalaivani, M., & Dinda, A. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.033 · Cited by 176
Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
Magnasco, A., Ravani, P., Edefonti, A., Murer, L., Ghio, L., Belingheri, M., Benetti, E., Murtas, C., Messina, G., Massella, L., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011080775 · Cited by 174
Self-citationChildren with Steroid-sensitive Nephrotic Syndrome Come of Age: Long-term Outcome
Rüth, E.-M., Kemper, M. J., Leumann, E. P., Laube, G. F., & Neuhaus, T. J. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.050 · Cited by 170
The Treatment of Minimal Change Disease in Adults
Hogan, J., & Radhakrishnan, J. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070734 · Cited by 167
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome
Nakayama, M., Katafuchi, R., Yanase, T., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31400 · Cited by 156
Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
Guasch, A., Deen, W. M., & Myers, B. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116831 · Cited by 156
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Hodson, E. M., Wong, S., Willis, N. S., & Craig, J. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003594.pub5 · Cited by 149
Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome
van den Berg, J. G., & Weening, J. J. (2004) · Clinical Science · doi:10.1042/cs20040095 · Cited by 148
Büscher, A. K., Beck, B. B., Melk, A., Hoefele, J., Kranz, B., Bamborschke, D., Baig, S., Lange-Sperandio, B., Jungraithmayr, T., Weber, L. T., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07370715 · Cited by 148
Larkins, N., Liu, I. D., Willis, N. S., Craig, J. C., & Hodson, E. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002290.pub5 · Cited by 144
Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome
Liu, L., Qin, Y., Cai, J., Wang, H., Tao, J., Li, H., Chen, L., Li, M., Li, X., & Li, X. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.018 · Cited by 139
The Nephrotic Syndrome and Its Complications
Cameron, J. S. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80170-1 · Cited by 139
Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes
Lennon, R., Singh, A. K., Welsh, G. I., Coward, R. J., Satchell, S. C., Ni, L., Mathieson, P. W., Bakker, W. W., & Saleem, M. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080940 · Cited by 131
New-onset diabetes mellitus after kidney transplantation: Current status and future directions
Palepu, S., & Prasad, G. V. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.445 · Cited by 127
AKI in Children Hospitalized with Nephrotic Syndrome
Rheault, M. N., Zhang, L., Selewski, D. T., Kallash, M., Tran, C. L., Seamon, M. L., Katsoufis, C. P., Ashoor, I. F., Hernandez, J. D., Supe‐Markovina, K., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06620615 · Cited by 117
François, H., Daugas, É., BENSMAN, A., & Ronco, P. M. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.015 · Cited by 107
Maas, R. J. H., Deegens, J. K., & Wetzels, J. F. M. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu355 · Cited by 104
Genetic screening in adolescents with steroid-resistant nephrotic syndrome
Lipska-Ziętkiewicz, B. S., Iatropoulos, P., Maranta, R., Caridi, G., Özaltın, F., Anarat, A., Balat, A., Gellermann, J., Trautmann, A., Erdoğan, Ö., et al. (2013) · Kidney International · doi:10.1038/ki.2013.93 · Cited by 93
Self-citationAnti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children
Ravani, P., Bonanni, A., Rossi, R., Caridi, G., & Ghiggeri, G. M. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08500815 · Cited by 92
Hashimura, Y., Nozu, K., Kanegane, H., Miyawaki, T., Hayakawa, A., Yoshikawa, N., Nakanishi, K., Takemoto, M., Iijima, K., & Matsuo, M. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1119-8 · Cited by 88
B7–1 Blockade Does Not Improve Post–Transplant Nephrotic Syndrome Caused by Recurrent FSGS
Delville, M., Baye, E., Dürrbach, A., Audard, V., Kofman, T., Braun, L., Olagne, J., Nguyen, C., Deschênes, G., Moulin, B., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015091002 · Cited by 87
Pereira, W. D. F., de Melo, G. E. B. A., Guimarães, F. T. L., Carvalho, T. G. R., Mateo, E. C. C., & Silva, A. C. S. E. (2013) · Inflammation Research · doi:10.1007/s00011-013-0672-6 · Cited by 84
Imbasciati, E., Gusmano, R., Edefonti, A., et al. (1985) · BMJ · doi:10.1136/bmj.291.6505.1305 · Cited by 81
Inhibition of the VEGF signalling pathway and glomerular disorders
Ollero, M., & Sahali, D. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu368 · Cited by 80
Regulatory T cells and minimal change nephropathy: in the midst of a complex network
Bertelli, R., Bonanni, A., Donato, A. D., Cioni, M., Ravani, P., & Ghiggeri, G. M. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12675 · Cited by 79
Williams, S. A., Makker, S. P., Ingelfinger, J. R., & Grupe, W. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198004243021701 · Cited by 77
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Wang, Y., Wang, Y., Tay, Y., & Harris, D. C. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00577.x · Cited by 76
Long-term linear growth of children with severe steroid-responsive nephrotic syndrome
Emma, F., Sesto, A., & Rizzoni, G. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1176-3 · Cited by 76
Self-citationIgA Nephropathy with Minimal Change Disease
Herlitz, L., Bomback, A. S., Stokes, M. B., Radhakrishnan, J., D’Agati, V. D., & Markowitz, G. S. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11951113 · Cited by 75
Pravitsitthikul, N., Willis, N. S., Hodson, E. M., & Craig, J. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002290.pub4 · Cited by 72
Élie, V., Fakhoury, M., Deschênes, G., & Jacqz-Aigrain, É. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1947-1 · Cited by 69
(1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80658-7 · Cited by 68
Time for Initial Response to Steroids Is a Major Prognostic Factor in Idiopathic Nephrotic Syndrome
Vivarelli, M., Moscaritolo, E., Tsalkidis, A., Massella, L., & Emma, F. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.12.020 · Cited by 63
Self-citationRisk Factors for Cyclosporin A Nephrotoxicity in Children with Steroid-Dependant Nephrotic Syndrome
Kengne, S.-W., Massella, L., Diomedi‐Camassei, F., Gianviti, A., Vivarelli, M., Greco, M., Stringini, G., & Emma, F. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01520209 · Cited by 60
Self-citationThe non-immunosuppressive management of childhood nephrotic syndrome
McCaffrey, J., Lennon, R., & Webb, N. J. A. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3241-0 · Cited by 57
Immunopathogenesis of idiopathic nephrotic syndrome with relapse
Sahali, D., Sendeyo, K., Mangier, M., Audard, V., Zhang, S. Y., Lang, P., Ollero, M., & Pawlak, A. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0415-3 · Cited by 51
Brodehl, J. (1981) · European Journal of Pediatrics · doi:10.1007/bf00442096 · Cited by 48
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
Webb, H., Jaureguiberry, G., Dufek, S., et al. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3245-9 · Cited by 43
Treatment of idiopathic nephrosis by immunophillin modulation
Meyrier, A. Y. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg1067 · Cited by 36
The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome
Canetta, P. A., & Radhakrishnan, J. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00078 · Cited by 33
Gbadegesin, R., & Smoyer, W. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04883-5.50018-0 · Cited by 27
Corticosteroid therapy for nephrotic syndrome in children
ORSINI, M., & Boscherini, B. (2015) · Nephrology · doi:10.1111/nep.12590 · Cited by 22
Vaccinations in children on immunosuppressive medications for renal disease
Banerjee, S., Dissanayake, P., & Abeyagunawardena, A. S. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3219-y · Cited by 16
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationIdiopathic nephrotic syndrome in children
Noone, D. G., Iijima, K., & Parekh, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30536-1 · Cited by 586
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Watts, A. J. B., Keller, K. H., Lerner, G., Rosales, I., Collins, A. B., Sekulic, M., Waikar, S. S., Chandraker, A., Riella, L. V., Alexander, M. P., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060794 · Cited by 397
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Mitrofanova, A., Merscher, S., & Fornoni, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00741-w · Cited by 356
Metadata
- Authors
- Vivarelli, M., Massella, L., Ruggiero, B., & Emma, F.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-12-09
- Volume
- 12
- Issue
- 2
- Pages
- 332-345
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2560560224
- Cited by
- 557
- References
- 68
- FWCI
- 20.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.